Investigation of structural stability and functionality of homodimeric gramicidin towards peptide‐based drug: a molecular simulation approach

Journal of Cellular Biochemistry - Tập 120 Số 4 - Trang 4903-4911 - 2019
P. Ganesan1, R. Rajasekaran1
1Bioinformatics Lab, Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, India

Tóm tắt

AbstractIncreasing death rates due to antibiotic resistance deteriorate the existing treatment measures. Antimicrobial peptides have turned into the emerging cure for multidrug resistance. However, the stability and functionality determine an antimicrobial peptide as a drug. Analyses of the homodimeric β‐helical peptide, gramicidin have suggested the significant role of gramicidin‐A, gramicidin‐B, and gramicidin‐C as antimicrobial compounds, but the structural basis for understanding the stability and functionality is insufficient to resolve multidrug resistance. To identify the best template among gramicidin types as a therapeutic product, we combined a detailed comparative static analysis and dynamic analysis along with conformational free energy and secondary structure prediction. We observed that the high intramolecular interactions and the geometrical features favored gramicidin‐A among other types of gramicidin. Our analyses further revealed that the secondary structure of gramicidin‐A showed β sheets with coils along the conformations without any disruption, thereby enhanced its membrane interactions in terms of binding free energy. In conclusion, gramicidin‐A has definitely showed enhanced structural stability and functionality; this could be considered the best template for a potential therapeutic product.

Từ khóa


Tài liệu tham khảo

10.1371/journal.pone.0117065

10.1016/j.bbamem.2007.05.011

10.1073/pnas.74.4.1478

10.1128/AAC.00124-10

10.1007/s007050050237

10.1007/s11010-015-2462-7

10.1007/s12013-016-0728-7

10.1002/jcb.25555

10.1080/07391102.2013.803264

10.1080/07391102.2012.759885

10.1007/s13277-016-5329-y

Ventola CL, 2015, The antibiotic resistance crisis, Pharm Ther, 40, 277

10.1021/bi010942w

10.1093/nar/28.1.235

10.1093/nar/gkn072

10.1002/prot.10104

10.1002/prot.20251

10.1093/bioinformatics/btu426

10.1093/nar/gkm423

10.1016/j.str.2017.01.008

10.1016/j.str.2007.09.017

10.1002/jcc.21127

10.1023/B:JCAM.0000035186.90683.f2

10.1002/jcc.20291

10.1016/0959-440X(92)90170-C

10.1155/2016/4101059

10.1002/jcb.26257

10.1016/0263-7855(96)00018-5

10.1002/prot.20019

10.1002/prot.21968

10.1110/ps.0217002

10.1016/j.sbi.2005.07.007

10.1042/BST0360027

10.1016/S0006-3495(97)78203-1

10.1016/S1097-2765(01)00426-9

10.1016/S0969-2126(97)00251-7

10.1038/nmeth0208-119

10.1002/prot.10410

10.1002/prot.20358

10.1002/(SICI)1097-0134(19980301)30:4<357::AID-PROT3>3.0.CO;2-G

10.2174/0929867043364496

10.1016/j.sbi.2004.03.009

10.1110/ps.062126106

10.1093/nar/gkr703

10.1016/j.ijbiomac.2012.05.008

10.1371/journal.pone.0025801

10.1002/prot.21960

10.1134/S0026893308040195

10.1007/BF01875422

10.1016/j.ijbiomac.2008.01.011

10.1146/annurev.bb.25.060196.001311

10.1016/0022-2836(76)90191-1

10.1038/nsb1096-842

10.1021/ja980182l

10.1021/bi00138a014

10.1039/C6MB00182C

10.1021/js950285r

10.1023/A:1012188625088

10.1073/pnas.102179699

10.1016/S0006-3495(97)78266-3

10.1110/ps.03411904